The St. James’s Hospital lung cancer biobank was established in 2004 in accordance with strict international biobanking guidelines. The biobank is internationally recognised as one of the largest lung cancer biobanks in the world.
This biobank is based on recognised best practice guidance which means that we can confidently guarantee that all specimens have been collected, processed, annotated and stored in accordance. All specimens are linked to an anonymised database that is maintained by a dedicated local database manager who is responsible for capturing all follow-up patient treatments and long-term survival.
The access to this bio-bank and its development, allows a considerable advantage for our clinical research in lung cancer.
Dr. Kathy Gately, Institute of Molecular Medicine